MoneyWorks4Me

Jubilant Life Science’s arm enters into SPA to acquire stake in Inipharm

29 Nov 2018 Evaluate

Jubilant Life Science’s wholly-owned subsidiary company -- Drug Discovery and Development Solutions, Singapore (DDDSL) -- has entered into Stock Purchase Agreement (SPA) on November 29, 2018 for acquiring 534,194 shares of Common Stock of Inipharm Inc., USA.

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..